Aigen Investment Management, LP Seagen Inc. Transaction History

Aigen Investment Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$117.37 - $139.17 $1.61 Million - $1.91 Million	13,718 Added 62.97%	35,503 $4.56 Million
Q3 2022 Nov 09, 2022	BUY	$135.27 - $180.11 $2.61 Million - $3.48 Million	19,328 Added 786.65%	21,785 $2.98 Million
Q2 2022 Aug 02, 2022	BUY	$108.81 - $179.33 $267,346 - $440,613	2,457 New	2,457 $435,000
Q1 2022 May 05, 2022	SELL	$119.61 - $157.85 $882,123 - $1.16 Million	-7,375 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$142.57 - $190.86 $1.05 Million - $1.41 Million	7,375 New	7,375 $1.11 Million
Q3 2021 Nov 12, 2021	SELL	$142.45 - $169.82 $2.35 Million - $2.8 Million	-16,480 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$135.08 - $161.1 $52,951 - $63,151	-392 Reduced 2.32%	16,480 $2.6 Million
Q1 2021 May 11, 2021	BUY	$137.51 - $190.8 $2.32 Million - $3.22 Million	16,872 New	16,872 $2.34 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.